Non-Invasive Management of Madura Foot with Oral Posaconazole and Ciprofloxacin

Amit M. Sharma Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York; Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York

Search for other papers by Amit M. Sharma in
Current site
Google Scholar
PubMed
Close
,
Namita Sharma Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York; Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York

Search for other papers by Namita Sharma in
Current site
Google Scholar
PubMed
Close
,
Amritpal Nat Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York; Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York

Search for other papers by Amritpal Nat in
Current site
Google Scholar
PubMed
Close
,
Meghan Rane Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York; Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York

Search for other papers by Meghan Rane in
Current site
Google Scholar
PubMed
Close
, and
Timothy P. Endy Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York; Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, New York

Search for other papers by Timothy P. Endy in
Current site
Google Scholar
PubMed
Close
Restricted access

Madura foot is a chronic infection caused by fungus and/or bacteria. Traditionally, treatment has been surgical debridement or amputation. Non-invasive management with long-term antimicrobials alone has been reported as successful. We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin.

Author Notes

* Address correspondence to Timothy P. Endy, Division of Infections Disease, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, 725 Irving Avenue, Suite 304, Syracuse, NY 13210. E-mail: endyt@upstate.edu

Authors' addresses: Amit M. Sharma, Namita Sharma, Amritpal Nat, and Meghan Rane, SUNY Upstate Medical University, Medicine, Syracuse, NY, E-mails: SharmaA@upstate.edu, SharmaN@upstate.edu, NatAm@upstate.edu, and RaneM@upstate.edu. Timothy P. Endy, Upstate Medical University, Syracuse, NY, E-mail: endyt@upstate.edu.

  • 1.

    Hershkovitz I, Speirs M, Katznelson A, Arensburg B, 1992. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol 88: 2326.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Kaufman MH, 2007. Sir George Ballingall (1786–1855): Regius Professor of Military Surgery in the University of Edinburgh. J Med Biogr 15: 7581.

  • 3.

    Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A, 2007. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146151.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    McGinnis MR, 1996. Mycetoma. Dermatol Clin 14: 97104.

  • 5.

    van de Sande WW, 2013. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2550.

  • 6.

    Ameen M, Arenas R, 2009. Developments in the management of mycetomas. Clin Exp Dermatol 34: 17.

  • 7.

    Parker L, Singh D, Biz C, 2009. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 48: 690.e15.

  • 8.

    Mahgoub ES, 1976. Medical management of mycetoma. Bull World Health Organ 54: 303310.

  • 9.

    Fahal AH, Shaheen S, Jones DH, 2014. The orthopedic aspects of mycetoma. Bone Joint J 96-B: 420425.

  • 10.

    Garnica M, Nucci M, Queiroz-Telles F, 2009. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 22: 559563.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Keating GM, 2005. Posaconazole. Drugs 65: 15531567, discussion 68–69.

  • 12.

    Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339346.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Zoller E, Valente C, Baker K, Klepser ME, 2010. Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther 4: 299311.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Jain V, Makwana GE, Bahri N, The MK, 2012. “Dot-in-Circle” sign on MRI in maduramycosis: a characteristic finding. J Clin Imaging Sci. 2: 66.

Past two years Past Year Past 30 Days
Abstract Views 1177 896 51
Full Text Views 429 12 0
PDF Downloads 153 13 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save